Presbyopia Drops: A Foundation for Future Care

Presbyopia drops are more than just a new tool—they’re a strategic entry point into the lifelong care pathway for patients with presbyopia.

1

Presbyopia drops serve as a strategic entry point into lifelong eye care, addressing immediate concerns while fostering long-term patient relationships.
2

Currently, three presbyopia drops are FDA-approved: Qlosi, Vuity, and Vizz, providing non-surgical alternatives for early-to-moderate presbyopes.
3

Customizability of presbyopia drops allows flexible dosing, empowering patients to manage their vision based on personal needs and lifestyles.
4

Clear communication about the temporary nature of presbyopia drops and the importance of neuroadaptation enhances patient satisfaction and retention.
5

Early engagement with presbyopia drops encourages proactive patient involvement in eye care, improving long-term outcomes and satisfaction.

1